21 CFR 316.1
§ 316.1 Scope of this part.
United States · 21 CFR — Food and Drugs · Status: effective
Cite this
- Citation
- 21 CFR 316.1, § 316.1 Scope of this part, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/86414
- Permanent ID
ys:prov:86414@1- SHA-256
d18085cb8ae095c7ef6a708e75fc4560d3a3099d9339ab17c19876cd83dd0288
The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.
Full text
(a) This part implements sections 525, 526, 527, and 528 of the act and provides procedures to encourage and facilitate the development of drugs for rare diseases or conditions, including biological products and antibiotics. This part sets forth the procedures and requirements for:
(1) Submissions to FDA of:
(i) Requests for recommendations for investigations of drugs for rare diseases or conditions;
(ii) Requests for designation of a drug for a rare disease or condition; and
(iii) Requests for gaining exclusive approval for a drug for a rare disease or condition.
(2) Allowing a sponsor to provide an investigational drug under a treatment protocol to patients who need the drug for treatment of a rare disease or condition.
(b) This part does not apply to food, medical devices, or drugs for veterinary use.
(c) References in this part to regulatory sections of the Code of Federal Regulations are to chapter I of title 21, unless otherwise noted.
Legislative history
This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.